Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Thuzar Thein, M.D., Ph.D.

Concepts (13)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Thuzar Thein's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Thuzar Thein has written about over time.
Carrier Proteins, 1 publications between 2013 and 2013, average publication date January 2013. Caspase 1, 1 publications between 2013 and 2013, average publication date January 2013. Cell Death, 1 publications between 2013 and 2013, average publication date January 2013. HEK293 Cells, 1 publications between 2013 and 2013, average publication date January 2013. Humans, 1 publications between 2013 and 2013, average publication date January 2013. Inflammasomes, 1 publications between 2013 and 2013, average publication date January 2013. Interleukin-1beta, 1 publications between 2013 and 2013, average publication date January 2013. Lysosomes, 1 publications between 2013 and 2013, average publication date January 2013. Macular Degeneration, 1 publications between 2013 and 2013, average publication date January 2013. NF-kappa B, 1 publications between 2013 and 2013, average publication date January 2013. Optic Disk Drusen, 1 publications between 2013 and 2013, average publication date January 2013. Retinal Pigment Epithelium, 1 publications between 2013 and 2013, average publication date January 2013. RNA, Small Interfering, 1 publications between 2013 and 2013, average publication date January 2013.

To see the data from this visualization as text, click here.
Thein's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (13)
Explore
_
Co-Authors (7)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.